Publication | Closed Access

Myocardial fibrosis and QTc are reduced following treatment with spironolactone or amiloride in stroke survivors: A randomised placebo-controlled cross-over trial

ThrombosisAntifibrotic TherapyHeart FailureCardiovascular DiseaseMedicineCardiovascular PharmacologyStroke SurvivorsMyocardial FibrosisPharmacotherapyPreventive CardiologyAcute Myocardial InfarctionPlatelet AntagonistStrokeCardiologyAnesthesiologyMyocardial Infarction